Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Celgene
Pharma
Court dismisses case against BMS' patent protection of Pomalyst
The lawsuit accused Bristol Myers Squibb of anticompetitive tactics in protecting the market exclusivity of Pomalyst.
Kevin Dunleavy
Apr 9, 2025 11:32am
Merck's Winrevair cuts death, morbidity risk by 76%
Mar 31, 2025 10:00am
BMS skates again on $6.4B Celgene shareholder lawsuit
Oct 1, 2024 10:45am
BMS accused of anticompetitive tactics to keep Pomalyst chugging
Sep 7, 2023 11:31am
BMS does away with the 'old me' in latest Zeposia DTC campaign
Jul 13, 2023 9:25am
Bristol Myers dodges one Celgene CVR suit, but more to come
Mar 2, 2023 10:40am
